Navigation Links
Lipid Association Responds to New Cholesterol Guidelines for Children
Date:7/10/2008

JACKSONVILLE, Fla., July 10 /PRNewswire/ -- When the American Academy of Pediatrics (AAP) issued its recommendation on July 7 regarding the treatment of children with high cholesterol, it generated a strong response from the community of medical professionals and patients. The National Lipid Association (NLA), a group of healthcare professionals who specialize in cholesterol and heart disease issues, believes that the AAP has acted in the interests of patient care by raising the issue of lipid abnormalities in children.

"Healthy lifestyles with good diet and exercise at an early age are the best level of prevention from future issues of related disease," says Dr. Thomas Bersot, president of the NLA and Professor of Medicine at the University of California in San Francisco. "We enthusiastically want children to participate in healthy choices and that parents, medical practices, schools, and the community should partner whenever possible to offer good interventions and choices."

Studies show that atherosclerosis often begins in childhood and adolescence, contrary to popular belief that this is a health concern only for middle-aged and elderly persons. In some affected children, such as those with the inherited disorder, familial hypercholesterolemia (FH), or in those whose parent suffered coronary artery disease (CAD) before 50 years of age, atherosclerosis progresses more rapidly, leading to heart attacks and death from CAD in their 30s, 40s and 50s.

For the majority of children, diet and lifestyle therapy are sufficient to achieve and maintain good health through adolescence and into adulthood. Early intervention for those who are overweight or obese in childhood is of key importance and the NLA concurs with AAP that a lifelong approach to cardiovascular disease (CVD) prevention is instrumental to our efforts to reduce death and morbidity from dyslipidemia. Indeed, the most recent issue of the National Lipid Association's Journal of Clinical Lipidology ( http://www.lipidjournal.com ) is entirely focused on pediatric lipidology and presents an in-depth exploration of the subject. We encourage further study in this area.

Much of the controversy surrounding the AAP guidelines appears to stem from a misinterpretation regarding the use of statins and other lipid-lowering drugs. These are options for managing specific genetic hypercholesterolemias such as FH, and severe hypertriglyceridemias. There is no randomized clinical trial data of statin treatment begun in childhood with regard to adult CAD event outcomes and it is unlikely that such data will be forthcoming for decades, if ever. However, the more common dyslipidemias correlated with insulin resistance and obesity should not be routinely managed with drugs, as diet and exercise remain the best treatment choices.

ABOUT THE NATIONAL LIPID ASSOCIATION

The National Lipid Association (NLA) is a multidisciplinary non-profit membership association that serves the community of healthcare professionals who manage patients with lipid disorders and cardiovascular disease. The NLA's public health mission is to help reduce deaths related to high cholesterol. For more information, please see the NLA Web site at: http://www.lipid.org.


'/>"/>
SOURCE National Lipid Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Simvastatin Leads Pfizers Lipitor in Second-Line Patient Share for the Treatment of Dyslipidemia
2. Significant Generic Erosion Will Cause Sales of Dyslipidemia Drugs to Decline by $3.6 Billion by 2016
3. Allergic response tied to lipid molecules in cell membrane
4. AUDIO from Medialink and the National Lipid Association: Whats Your Triglycer-IQ?
5. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
6. Use of certain lipid measures not more effective in predicting coronary heart disease
7. Statement on CDC Announcement That 70 Percent of the U. S. Population Now Receives Optimally Fluoridated Water By Mark J. Feldman, DMD, President, American Dental Association
8. Global Access Project (GAP) Study Examining Patients Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA)
9. Neurogenesis in the adult brain: The association with stress and depression
10. Blue Cross and Blue Shield Association Statement: Health Care America Now
11. American Parkinson Disease Association Awards More Than $3.7 Million to Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... Ron Norman, ... how to use the Law of Large Numbers in favor of senior, upper-level executive ... Las Vegas casinos, have long understood the Law of Large Numbers as a way ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... As the ... news site, https://dealfeed.sutlr.com . People are constantly trying to find tips and stories ... industry, Sutlr deal feed brings you the top trending deals. The deals are organized ...
(Date:9/26/2017)... Plains, NJ (PRWEB) , ... September 26, 2017 ... ... Fellowship trained orthopedic surgeon and the Chair of the Leg, Ankle, and Foot ... Kovatis is currently the only fellowship trained orthopedic surgeon at Hackensack UMC performing ...
(Date:9/26/2017)... ... 26, 2017 , ... “How to Live in the Millennium”: a gripping take on how ... no longer a part of everyday life and do not affect daily choices. It ... for the thoughts, words, and actions that are chosen. “How to Live in the ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... “Sonflower Submission”: ... a strong-willed nature to the inevitable destinations of negativity, complaining and the need to ... side to take effect in order for a lesson in stress-less living to be ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... TORONTO , Sept. 6, 2017 /PRNewswire/ ... new knowledge and skills while treating their ... for hands-on experience without involving patients. Simulation ... skills. Clinicians can carry out procedures, refine ... at risk. Integration of new technology, such ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: